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Abstract
Background: Many European countries have recently implemented national rare disease plans. Although the network
is strengthening, especially on the macro and meso levels, patients still go a long way through healthcare systems,
with many health professionals involved and scarce evidence to gather. Specifically, patient involvement in the form of
shared decision-making can offer further potential to increase healthcare systems’ efficiency on a micro level. Therefore,
we examine the implementation of the shared decision-making concept thus far, and explore whether efficiency
potentials exist—which are particularly relevant within the rare disease field—and how they can be triggered.
Methods: Our empirical evidence comes from 101 interviews conducted from March to September 2014 in Germany;
55 patients, 13 family members, and 33 health professionals participated in a qualitative interview study. Transcripts
were analyzed using a directed qualitative content analysis.
Results: The interviews indicate that the decision-making process is increasingly relevant in practice. In comparison,
however, the shared decision-making agreement itself was rarely reported. A majority of interactions are dominated by
individual, informed decision-making, followed by paternalistic approaches. The patient-physician relationship
was characterized by a distorted trust-building process, which is affected by not only dependencies due to
the diseases’ severity and chronic course, but an often-reported stigmatization of patients as stimulants. Moreover,
participation was high due to a pronounced engagement of those affected, diminishing as patients’ strength vanish
during their odyssey through health care systems. The particular roles of “expert patients” or “lay experts” in the rare
disease field were revealed, with further potential in integrating the gathered information.
Conclusions: The study reveals the named efficiency potentials, which are unique for rare diseases and make
the further integration of shared decision-making very attractive, facilitating diagnostics and disease management. It is
noteworthy that integrating shared decision-making in the rare disease field does not only require strengthening the
position of patients but also that of physicians. Efforts can be made to further integrate the concept within political
frameworks to trigger the identified potential and assess the health-economic impact.
Keywords: Shared decision-making, Rare diseases, Expert patient, Patient preferences, Patient centered care, Qualitative
research
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Background
The relevance of shared decision-making and patient
perspectives
Historically, a paternalistic decision model has been estab-
lished within several healthcare systems [1, 2]. However,
as healthcare systems shift toward patient-centered care,
the patient’s role has become increasingly prominent. In-
tegrating concepts of evidence-based medicine and patient
perspectives, such as the inclusion of patient preferences,
has also become increasingly relevant [3, 4].
The concept of shared decision-making (SDM) was
first mentioned as such in 1982 [5]. It has been posi-
tioned as a centerpiece between paternalistic models, in
which physicians dominate the decision-making process,
and an informed patient choice model, in which the
physician provides information but the patient assumes
a leading role [4, 6]. The most often-cited concept origi-
nates from the work of Charles et al. [6], who defined
SDM as a collaborative process between patient and
provider based on a discussion of options, evidence, and
potential benefits and harms; this especially considers
the patient’s preferences and situations [6].
A review of literature published between 1996 and
2011 by Blanc et al. [7] identified 1285 out of 229,179
publications in 15 journals addressing the topic of SDM.
In this context, it was identified that publications in
medical journals increased exponentially during this
period, which indicates the topic’s growing relevance.
However, the meaning of SDM is often assumed rather
than interpreted through SDM testing models [8]. Other
studies suggest that existing SDM models only partially
reflect the factors that influence patient empowerment
or the breadth of their further potential [9, 10]. Litera-
ture suggests that SDM concepts augment patients’ sat-
isfaction with the healthcare system, especially regarding
the quality of care [12]. Further, this can also positively
affect health outcomes. Patients’ poor compliance and
inappropriate use of medicines arise from poor commu-
nication, the patient’s lack of understanding of how the
drug is expected to work and its potential side effects,
and a failure between the patient and physician to find a
common ground or concordance [13, 14]. Desrroches et
al. [4] suggest that SDM should be chosen as an ideal
chronic disease strategy to improving compliance with
medications and therapeutic processes, which is a major
public health issue. This suggests a particular relevance
regarding diseases with chronic life cycles.
Nevertheless, healthcare professionals consistently fail
to facilitate patient involvement, and even fewer include
patient preferences in care [15]. An appropriate level of
SDM does occur in practice, although only in approxi-
mately 10% of cases [16], suggesting that although litera-
ture broadly covers the SDM process, further efforts are
still necessary to expand its usage.
The rare disease context
Estimations reveal that approximately 350 million people
are affected by rare diseases worldwide. Many rare dis-
eases can be traced to a genetic origin, often linked to a
chronic course of diseases as well as severe symptoms
[17]. Although various different health conditions affect-
ing different parts of the human body are subsumed
under the term “rare diseases,” these people share common
difficulties [18].
Consequently, worldwide rare disease national plans
have been implemented, with 20 implemented overall
in Europe from 2004 to 2014. These policies focus on
centers, networking, research, disease registries, cod-
ing, therapies, information provision, and patient
organization [19]. In this regard, patients are solely
and indirectly included through patient organizations.
However, the German National Plan for cancerous
diseases indicates that direct patient involvement is
also strengthened through empathetic communication
and including patients in decision-making, as noted in
action field number 4 [20].
On the one hand, information needs and preferences
have already been examined in the rare disease field
[21–23]. However, concepts of shared decision-making
have thus far only been evaluated in such contexts as
diabetes [8], mental illnesses [9], coronary heart disease
[24], and cancer screening programs [25]. Evaluations
regarding rare diseases that include all people affected as
well as physicians are still lacking.
On the other hand, physicians can provide extensive
information on treatment options and managed care
contracts in prominent disease areas, such as diabetes
and cancer. However, information in the rare disease
field is often scarce, and those affected often become
“experts” of their own disease by capturing substantial
information during their long odyssey through health-
care systems [26].
The study’s aim
Triggering this information through effective informa-
tion exchange strategies, such as shared decision-mak-
ing, could contribute to the efficiency of, and overall
satisfaction with, healthcare systems. Therefore, the
purpose of the underlying study is to examine the imple-
mentation of the SDM concept in Germany. Further, the
study explores whether efficiency potentials exist for the
healthcare system within the rare disease field. The
triangulation of patient interviews with family members’
and physicians’ opinions controls for the results’ validity
and practicability. The results also contribute to the
framework of shared decision-making, as this framework
identifies potentials resulting from the specifics of rare
conditions.
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Method
The study was based on Mayring’s qualitative research
methodology [27]. A qualitative setting was chosen as
the goal to observe a holistic picture of SDM, rather
than analyze by focusing on the research topic’s
provisional aspects [28]. The qualitative setting also
allows participants to independently address important
aspects. Therefore, the outcomes illustrate participants’
current, actual experiences, and are not channeled by
interviewers. The material was collected through semi-
structured interviews and evaluated based on a qualita-
tive content analysis in an inductive-deductive approach.
The research items in this context are chosen from
existing concepts, and all evolving topics in the evalu-
ation process are assigned to the research items and the
evolving subcategories [27].
This study’s empirical evidence is derived from three
data sets, offering information on three comparison
groups. These sets were chosen by considering the infor-
mation rendered on the research topic, and whether the
sets contribute more to a rich description then one data
set alone [29]. Further, comparisons within qualitative
research add more to the full understanding of the issue
than analyzing differences [30]. Hence, this study trian-
gulates patients, or the directly involved; their relatives,
or the indirectly involved; and physicians, as the coun-
terparts within the decision-making process. Therefore,
the comparison groups’ different perspectives could be
carved out.
Participant recruitment
Overall, a qualitative, non-random quota-sampling tech-
nique was used. In this context, the population is first
determined regarding specific qualities, and certain
quotas are then recruited from these subgroups [31].
Patients and family members were recruited by the
Freiburg Centre for Rare Diseases at the Department of
Dermatology of the University Medical Centre. As “rare
diseases” summarizes many conditions with different ap-
pearances, the goal was equal coverage of the following
disease areas (n = 11): skeletal dysplasia, neuromuscular
disorders, immunodeficiencies, genetic eye disorders,
genetic skin disorders, connective tissue disorders, gen-
etic kidney diseases, cystic fibrosis and lung diseases, an
inherent disturbance of hematopoiesis, inherent meta-
bolic disturbances, and genetic diseases of the digestive
tract. However, the interview results often indicated an
overall complex, systematic involvement. We also strive
for a balanced recruiting of female and male partici-
pants, as well as a participant from different age groups.
We included at least nine patients with a long path to
diagnosis, defined as lasting at least 10 years. The inclu-
sion of relatives was necessary, as many rare diseases
affect children, who are ineligible for interview, and
participants needed to be at least 18 years old. Alterna-
tively, a close relative was invited to answer the ques-
tions. Potential participants were chosen from the rare
disease center’s clinical register and were contacted as
part of a clinical visit with visiting patients randomly
chosen. Patients did not agree to participation in ad-
vance. Further, all participants who signed an informed
consent agreement and were assigned to an interviewer
remained in the study.
The interviewed physicians are part of the field of
action of people affected by rare diseases defined as such
by Meuser and Nagel [32]. Physicians as health experts
serve to supply information from the operating contexts
of those affected, covering the overall spectrum of the
providing health care structure [32]. Therefore, physi-
cians were selected in accordance with their profession,
including general practitioners, specialists, and clinicians.
Moreover, guides in the rare disease field were also
questioned. The term “clinicians” in Germany represents
medical experts working in hospitals, while “specialists”
operate in private practice. Guides differ in their qualifica-
tions and are equally trained to direct patients suffering
from rare diseases, but were only included in instances in
which a medical background could be determined. The
Centre of Quality and Management in Health Care, in the
State Medical Chamber of Lower Saxony in Hannover,
was responsible for recruiting medical professionals. All
physicians were recruited within the geographic region of
Lower Saxony, representing both urban and rural areas in
Germany. As clinical guides occur less frequently, this en-
tire subgroup was recruited from all regions in Germany.
The following criteria were employed to create appropri-
ate subgroups: residence, such as rural, urban, or metro-
politan; single versus group practice; medical care level,
such as basic, regular, specialist, and maximum; and level
of the physician’s medical experience, with hierarchy levels
of assistant physician, senior physician, and chief phys-
ician. A physician’s hierarchy level is referred to as an indi-
cator of the experience of hospital physicians. Therefore,
different modes of employment, called “hierarchy levels”
in this case, were differentiated. In German hospitals,
three different professional positions are common, begin-
ning with the lowest level of “assistant physician,” followed
by “senior physician,” and then the most experienced level
of “chief physician”. Therefore, the sample covers the
heterogeneous area of healthcare provision relative to the
research topic of interest, and thus, covers the field of
action defined by Meuser and Nagel [32] regarding physi-
cians as experts on rare diseases in Germany.
Data collection
Three different interviewers queried patients and family
members between March and November 2014, while
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two other interviewers met with physicians between
April and October 2014.
Interviews were held face-to face (patients and rela-
tives: 40; physicians: 26) and by telephone (patients and
relatives: 29; physicians: 7). Not all interviews could be
conducted face-to-face due to appointments on short
notice, the need for extensive disproportionate travel, or
participants’ preference.
Interviews were conducted according to a semi-struc-
tured interview guide. The interview guide was devel-
oped during a mutual workshop of the research group
led by an experienced external qualitative researcher.
The qualitative researcher presented the relevant quali-
tative research guidelines. Afterwards, the research
group presented the potential interview questions.
During our mutual discussion, questions were adapted
further, as the first draft included questions that did not
induce narration appropriately. The second drafts of the
question and sub-question sets containing further minor
wording adaptions was sent to the research group via
email to reach a final consensus on the question set. The
interview flow was initiated through a narrative question
requesting rare disease experiences from the onset.
Sub-questions concerned the diagnosis, and therapy and
disease management were only posed when questions
were not autonomously addressed. This approach was
chosen to identify emerging SDM aspects, rather than
proffering the SDM concept for the participants. Thus,
we strove to avoid overestimating SDM effects, which
can occur due to expressive reporting, when directly
inquiring about a concept. Further, requests were made
as interviewers observed the necessity. Questions on in-
formation-gathering behavior and interchanges were
subsequently posed.
The interview study was embedded into the creation
of a national rare disease Internet platform in Germany
(Zentrales Informationsportal über seltene Erkrankungen,
or “ZIPSE”), which enables patients and family members
to actively gather quality-assured evidence [33].
The interview guide was pretested with one patient
and one family member, and was then adapted to include
the perspectives of participants who have experienced
their diseases since birth. The following interviews appro-
priately covered the different courses of rare diseases, and
therefore, this study could optimally cover the different
paths through the healthcare system and interactions with
healthcare specialists could be ideally covered. The physi-
cian’s interview guide was accordingly developed to align
the guide’s structure, and was pretested by interviewing
one physician (female, 43 years). Piloting the interview
guide demonstrated that relevant cases could be appropri-
ately triggered based on the interview guide. Nevertheless,
some adaptations were necessary, as the healthcare profes-
sionals offered different perspectives on the topic. The
research group mutually reviewed both interview guides
to align standardized procedures. We first conducted a
trial run of an interview to practice the procedure and
control for the fit of the posed interview questions. During
the following interviews, participants’ pathways through
the healthcare system, also referring to interactions with
the contacted medical professionals, diagnosis, and poten-
tial therapies, as well as the diverging information sources
and/or information access points, were well described.
Qualitative research also gives the option to further adapt
the interview guide along the way. Therefore, we continu-
ously checked for further adaptation needs. However, due
to in-depth narration of interviewees and coverage of the
addressed topics, no further adaptations were deemed
necessary.
Data analysis
All participant interviews were audio recorded, and
later transcribed with the aid of F4 transcription
software (Version 6, Dr. Dresing & Pehl GmbH in
Germany). A standardized interview protocol was also
distributed to interviewers of patients and family mem-
bers to document any special circumstances potentially
relevant in interpreting the collected data. A standard-
ized transcription booklet was developed for patients,
relatives, and physicians, and was used as a transcrip-
tion guideline. The transcription booklet offers a stan-
dardized definition of different transcription strategies
and codes, where diverging options were possible. This
defined the anonymization of participants and loca-
tions, as well as the handling of any incomprehensible
audio sections.
All steps of a qualitative content analysis were then
recognized [34]. Hence, transcripts were analyzed based
on a directed qualitative content analysis [27]. An in-
ductive-deductive approach was used. Predefined items
were identified in a deductive first step using Charles et
al.’s [6] predominately used definition of SDM. Therefore,
the following items were noted: 1. The “patient-physician
relationship,” 2. “Participation,” 3. “Information exchange,”
and 4. “Decision-making.” Second, subcategories were de-
veloped, assigned and revised in a stepwise procedure fol-
lowing Mayring’s [27] inductive category development
process. Finally, two further researchers revised the evolv-
ing items to ensure both formative and summative reliabil-
ity and any differences were addressed and included in the
data analyses. Ultimately, the patients’, family members’,
and physicians’ results were triangulated. Evolving items
from physicians’ and relatives’ interviews were matched
with already identified items from patients’ interviews,
where appropriate. Otherwise, a new subcategory was
deemed necessary. All quotations were reviewed by a na-
tive speaker.
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Results
Appendix 1 displays detailed characteristics for the par-
ticipating patients, family members, and physicians.
Overall, 55 patients, 13 family members, and 33 physi-
cians were interviewed as a part of the study, although at
least one participant could not independently participate
in the interview study due to the severity of their illness.
The patients’ median age was 52, family members was
44, and physicians was 48; 67% of patients, 61% of family
members, and 30% of the physician subgroup were fe-
male. The diseases’ severity were self-assessed, with 9%
of patients rating their disease severity as mild, 47% as
medium, and 38% as severe. 6% did not state any
specifications.
The interview results were marked with a code con-
sisting of an interview number and letter: “P” represents
the patient, “A” represents an “acquaintance or family
member,” “GP represents the general practitioner,” “CP”
represents clinical physicians, and “EP” represents expert
physicians. The following themes regarding experiences,
decision-making processes, and information exchange
procedures were identified in the rare disease field:
Item 1: the relationship between patient and physician
Nurturing trust-building processes
Patients report that trust is an important basis for effect-
ive communications about their disease. If a relationship
of trust has not evolved, patients will prefer to make
their decisions and search for the answers to their health
questions on their own, often through the Internet (P37).
Communication can lay the foundation for a trusting
relationship. For example, one physician reported that she
would not write reports, but trusted the patient’s under-
standing of their rare disease (GP02).
Moreover, a trusting relationship is nurtured when
physicians admit the limits of their knowledge of rare
diseases and make the appropriate contacts to compen-
sate for this gap (GP04, GP08). A trusting relationship is
particularly strong when patients can obtain answers to
current health questions—no matter how straightfor-
ward—and when physicians take the time to research
and discuss these questions with their patients (P06).
Several aspects within the patient-physician interaction
must be considered to avoid mistrust. Our patient respon-
dents were disappointed with highly qualified physicians
who lack information about rare diseases (P05, P08, P27).
Patients also believed that physicians could hardly
empathize with their conditions (P22), and searched for
medical professionals who cared (P27). This, and the lack
of a constant contact person, especially in outpatient care,
led to high dissatisfaction and patient mistrust. Alterna-
tively, patients positively perceived the existence of a per-
manent contact person (P01, P24). Further, a relationship
of trust is undermined by misdiagnoses (P05, P17), as
patients recognize that physicians experience difficulty in
diagnosing rare diseases. Although they somewhat under-
stand physicians’ struggle, patients also reported the need
to search for a physician capable of diagnosing their
disease (P34). Moreover, disappointment occurs when
treatment is denied as a result of a high-risk disease classi-
fication due to comorbidities or age (P06, P38). Family
members also report that they need to verify physicians’
information regarding treatment considerations, as ther-
apy options are often scarce or newly developed, and they
rather feel like “guinea pigs,” which feeds their distrust
(A09). It is also reported that no elucidation by the
physician occurred, although the diagnoses were already
established, which increased suspicion (A10). The next
step may involve a further increase in mistrust if pa-
tients—or family members, in this case—do not acquiesce
to the opinion offered during the medical consultation
(A05).
Dependencies
On the one hand, rare diseases often exhibit a chronic
course and the relationship between patients and physi-
cians is often characterized by dependence, which also
highlights the importance of a positively perceived
relationship. On the other hand, negative perceptions
can lead to a change of physician. Those affected can
organize in patient networks or self-help groups, which
help them feel supported; therefore, they become
empowered and can assume more responsibility for their
disease management (P30).
Family members also report that one must be “lucky”
to find an appropriate physician (A04), or that one “re-
lies on a physician for better or worse” (A02).
The psychosomatic corner
It was found that physicians complain about patients
who return with the same problems. As rare diseases are
difficult to diagnose, patients suffering from rare diseases
on the long path toward diagnosis may be categorized as
psychosomatics, simulants, or hypochondriacs, or suffer-
ing from psychological problems, which further under-
mines a positive patient-physician relationship (A06,
P08, P16, P22, P27, P28, P39, P49, P52, P56). Conse-
quently, patients do not believe they are taken seriously,
which can also lead to them terminating their treatment
(A06, P12). Physicians also reflected upon the difficulty
in diagnosing rare diseases and the problem of over-re-
ported symptoms due to Internet information (CP01,
CP05, EP02); however, these areas of interest are not
linked.
Other participants
Patients also consider the recommendations of others
affected through rare disease self-help groups. Other
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physicians are also predominantly involved, as diagnostic
procedures may span a longer time period, and many
different fields of expertise may be involved due to poly-
systemic patterns. Patients even noted that they are glad
when physicians cooperate with the resulting “referral
marathon” (P13).
However, many patients reported their struggles
when shifting from one physician to the next. This is
especially the case when crossing the boundary from
the stationary to the ambulatory healthcare sector, in
which patients are confronted with a loss of informa-
tion or a lack of information transfer, as it is assumed
that other physicians are responsible for communica-
tion, or that this communication has already occurred
in other events (A07, A08, P05, P13, P14, P18, P24,
P26, P27, P28).
The following Table 1 summarizes the findings for
Item 1 and provides corresponding anchor examples:
Item 2: participation during the decision-making process
Physicians’ commitment
Participation is perceived as minimal when no time
seemingly exists to build an in-depth, trust-based pa-
tient-physician-relationship (P06). Patients were espe-
cially disappointed when physicians did not demonstrate
engagement during the particularly long diagnosis
process, with successive symptoms in the rare disease
field (P19, P56). This was interpreted as a lack of effort
to link symptoms in a networking approach (P06) and a
lack of interest to further analyze the diagnosed disease
(P50).
Alternatively, physicians expressed anger in not con-
sidering a rare disease (GP03). Further, a diagnosis is
critical for patients, and especially when they experience
a long path from their first symptoms to diagnosis. In
this case, the patients strive to self-diagnose, for ex-
ample, by making their own appointments for a verifying
biopsy (P49). This importance is highlighted by their de-
scribing the difficulty in arguing for an understanding of
their special physical needs due to their symptoms in
front of family, friends, and colleagues with no diagnosis
to build upon (P56).
Similarly, family members report that they even feel
neglected by their pediatricians (A03). Patients’ reports
also reveal that physicians must invest substantial time
to work up the course of rare diseases, as patients
experience a long path to diagnosis (P07). Physician re-
spondents reported that cases take several weeks to work
up (GP01).
The physicians also stated that the diagnosis does
include a naming of the disease, but no scope, leading to
limited decision-making (GP07). In this regard, they
would like to offer more, but are bound to offer less due
to limited therapy options or missing curative therapies
within the rare disease field (P14).
Patients’ commitment
A particularly active form of engagement can be ob-
served in family members, who described driving 500 km
to search for a well-trained pediatric orthopedist or a
specialized center for rare diseases (A01, A02, A06).
Physicians also highlight the particular engagement of
family members, who urge proper diagnoses with the
help of Internet information (A01, CP06, EP07). In this
regard, physicians also emphasize the importance of
engaged patients, as physicians need their participation
to obtain anamnesis data they could not otherwise
obtain (EP04).
Table 1 Anchor examples for the “relationship between the patient and physician”
Identified Items Anchor Examples
Nurturing trust-building
processes
“[...] But [regarding] the counseling, people often ask, ‘What do you say about that? What should I do? Should I really choose
a hearth catheter, or should I drop it? What do you say about that?’” [Interviewer: ‘Hm.’] “And when I say, ‘Yes, go!’ or when I
say, ‘No, don’t go!’—” [Interviewer: Hm] “That’s absolute. That’s what I experience again and again. They confide very much
in our opinion. And when we endorse something, then it’s okay, and if we do not, then it’s not.” (Primary physician, female,
47 years old, GP03)
“[...] As noted, one has no chance with physicians with such a disease. […] There are rare diseases, that’s disastrous. And
physicians get a chance, somehow, to search for anomalies, to get clues about which diseases can be considered. In my
case, it was rather stupid, as liver values were so much in the foreground; however, one only needed to regard the
thrombocyte values. I don’t know how this can be done in an intelligent way, as based on this or that, it can be that. But
private physicians in particular have a hard time identifying a proper diagnosis. And many people do not have the energy to
transfer from one doctor to the next, as I do. Yes, that’s what one does.” (Patient, male, P34)
Dependencies “[...] In the new city I live in, I have gone to hematologists, with whom I have not gotten along with at all, and the personal
contact within the network has encouraged me to simply say, ‘No, I have a chronic disease and I am relying on that
physician; if I do not get along with him, I need to change the physician.’” (Patient, female, P30)
The psychosomatic corner “[…] And many physicians are still of the opinion that if there are no identifiable causes, then it is psychological. Then there
are many dystonia patients who need to fight [the opinion] that this is simply not psychological, but neurological.” (Patient,
female, P39)
Other participants involved “I am lucky to have physicians who play along with this ‘referral marathon.’” (Patient, female, P13)
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Alternatively, patients also describe a passive form of
interaction, in that they trust physicians’ expert knowledge
and hope that they will share all relevant information. This
subsequent form of interaction is a “supervisory” relation-
ship (P55). Physicians also report that patients who are
unwilling to cooperate (GP05) as well as those who are
willing to co-operate especially experience high psycho-
logical strain, which they want to ameliorate or share
(GP03).
The following Table 2 summarizes the findings for
Item 2 and provides corresponding anchor examples:
Item 3: information exchange
Professional health knowledge on rare diseases
Patients appraise broad rare disease knowledge, which is
interconnected with the trust-building process (P05).
Patients also report satisfaction with a single contact
point when expert information is attained (P02). How-
ever, patients must independently search for rare disease
health experts, as health information on rare diseases is
perceived as generally scarce (A08, A11, GP01, P17, P34,
P38). Patients repeatedly reported that they are lucky to
have found someone on short notice who can diagnose
their disease (P47). Patients also felt uncomfortable
when realizing that physicians need to research their
sometimes incredibly rare disease (P49). Physicians
noted that comprehensive guidelines augment this
dilemma by making it difficult for patients to fall within
general medical guidelines (EP03). Problems arise when
a lack of information leads to misinformation that must
be clarified by other health experts (P05). However, this
process can be positively transformed by not only
explaining the knowledge gap in rare diseases, but also
transferring the case to experts on the disease (P55).
Relative to health information needs, patients request
information on innovative health procedures, for ex-
ample (A08). When patient questions regarding their
diagnosis remain unanswered, this feeds dissatisfaction
and mistrust (P15, P16, P28). Patients are sometimes
offered initial information, such as a diagnosis, and
are subsequently asked to proceed by themselves to
the next steps, such as finding information on the
disease and searching for a proper physician (P08).
However, physicians also highlighted the limitations
of Internet information, and especially emphasized
that physicians must take patients in hand when thor-
oughly structuring and sorting the gathered informa-
tion (EP09). While physicians offer only indication
names, self-help groups can render further in-depth
information (A02). Moreover, patients acknowledge
that it is impossible for physicians to grasp the entire
spectrum of a rare disease’s effects, which are often
linked to genetic mutations (P49).
Health information scope: between feeding fear and
effective health management
Patients reported ambiguity about the scope of health
information communications; on the one hand, they
demand more information on diagnoses and diseases’
possible courses (P12, P24). On the other hand, some
patients hold back information crucial for diagnosis due
to a sense of shame (GP03). A diagnosis without further
information exchange triggers a process of concern or
dissatisfaction within patients (A10, P12, P24, P32).
Some patients reported struggling with a language bar-
rier resulting from the extensive usage of professional
jargon, and needed more simplified information (P12).
Patients reported feeling like “guinea pigs” when infor-
mation was not rendered to a sufficient extent (P29).
Presumably, patients’ parents in particular tend to exten-
sively worry. In this regard, information should be
communicated by keeping the patient and family mem-
bers grounded and explicitly integrating reassurance as
an instrument (GP09). Other physicians complained
Table 2 Anchor examples of “participation during the decision-making process”
Identified Items Anchor Examples
Physicians’
commitment
“Yes, […] I think that is the interesting part of the issue. Basically, the point is, they do not take into account this hypothesis. Simply,
they always think about the obvious, at present, or what that could be. And basically, ‘It is not even a complex disease, and […]
not even complicated to diagnose,’ [and they think,] ‘Oh, I can also add something about the diagnosis later on.’ But, one also
needs to come up with it first. And there is the statement of the physician, whom I told that I suspected I have achalasia, and who
then said, ‘Oh, that’s so rare; that’s not what you have for sure.’ They do not search for this.” (Patient, female, P56)
“[...] And somehow, one has a contact person, and I have the feeling, and the neurologist says, ‘It is good that you take Valacliclovir,




“So, in the run-up, a catastrophe [occurs] because one really has nobody [without a] diagnosis, [and it is] extremely difficult to
somehow find the right doctor. Actually, there is, or there was at that point, as we started searching, […] no such centers for rare
diseases that were developed during the last few years. And therefore, I should say, one naturally depends on the pediatrician in the
first line, and one has to simply, that’s what we felt, have luck to get to the right physician.” (Family member, male, A06)
“[…] Shingles, send a picture, then you know what it is. But when it’s something rare: no chance. But, you need to talk to the
patient, you need anamnesis data.” (EP04)
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about a communication filter system, in that a question-
naire is first rendered, a doctor’s assistant reviews the
notes and the physician himself is finally consulted
(EP02).
The “expert patient”
Patients described themselves as deliverers of informa-
tion on rare diseases, and they close existing knowledge
gaps through the use of Internet information, for
example (A03, P21). Younger physicians (KA04, KA06)
in particular wished to individually inform patients
through, for example, web-based information sources,
but were concerned with other physicians’ negative reac-
tions (P08, P30). In this regard, patients even described
themselves as “good” patients when blindly trusting their
physician (P12). Alternatively, physicians also reacted
positively toward individuals’ searches for health infor-
mation through web-based sources (EP01, EP11, KA07).
Although those affected are aware of the limited quality
of Internet information, such as the broad spectrum of
users in web-based forums (A13), physicians perceive
themselves as necessary information filters (EP09). More-
over, some health professionals discourage patients to
search for web-based health information, as it is difficult
to properly classify such information, leading to increased
concerns (EP03, KA01, KA05, KA09). Physicians were
concerned that the false alarms caused by misconceptions
from Internet information could hinder the resources
within healthcare systems that different positions urgently
require (GP04). Other physicians differentiated between
handling anxious patients, and discouraged information
searches, and other patients, who are allowed to search for
Internet health information (EP11).
Patients described a knowledge-gathering process in
which they “hop” from one physician to the next and
gather information from a primary information access
point: the self-help group (A01, A02). Further informa-
tion sources with growing importance include the expert
centers for rare diseases, developed at university clinics
throughout Germany. Those affected describe the know-
ledge transportation process from the center to the local
consultant, in which the consultant takes the leading
role by communicating the next steps in the medical
process (A13). Patients’ high responsibility regarding
their medical information and the search for physicians
can be interpreted as a hurdle on the path to SDM.
Further, patients may feel left to their own fate rather
than achieving mutual health goals. As these centers
increase in number, this step is also increasing in im-
portance, and physicians discourage the use of forums
due to the doubtful quality of their health information
(GP03, EP03).
Information delivery is demanded at an earlier stage,
in this case immediately at diagnosis (P31). In this
regard, patients also remarked that they needed to urge
physicians toward information generation, emphasized
that these health experts are likely to forget that each
patient must be informed from the onset, and demanded
different scopes of information (P34).
Alternatively, patients also reported that those affected
needed to inform physicians about their disease when
they changed their permanent location and searched for
a proper specialist (A06). Physicians complained that the
reporting obligation does not exist due to a lack of
obligatory transfers, resulting in the need to ask patients
for their documents or call the prior provider (CP05,
GP01).
Other patients noted that they communicated with
physicians at the same level, avoiding unbalanced com-
munication (P03). Patients suffering from rare diseases
even urged physicians for a diagnosis, as their symptoms
are often genetic. However, they were also thwarted by
the physician, who stated, “How can you take upon
yourself the right to intervene with the medical decision-
making process? (P09)” Patients also tended to transfer
on their own, by taking responsibility for their own
disease management (P17).
Patients are called health “experts” on their own
diseases, as they have unique knowledge on their symp-
toms and can gather information on their individual
form of the disease (CP07). Similarly, family members
are also called “lay experts,” as they also extensively
gather and exchange health information (GP09).
The following Table 3 summarizes the findings for
Item 3 and provides corresponding anchor examples:
Item 4: decision-making and agreement
Paternalistic communication
Paternalistic decision-making is unavoidable, and espe-
cially in emergencies (P17); transfers are also suggested in
a paternalistic way (P06). Further, patients under diagnosis
may not be asked whether they wish to be informed (P11,
P28), and physicians may define the specifics of thera-
peutic interventions, and especially dosages (P22). Patients
and family members described physicians who wished to
convince them of a specific therapy option, and urged
them toward a specific outcome, such as surgery (A05,
P21). However, patients searched for a second opinion in
severe interventions, ruling out alternative therapy op-
tions. (P51).
Some patients reported perceiving a paternalistic com-
munication as positive due to the perception of protection
(A09).
One patient opposed shared decision-making as well
as the associated discussions, and noted that he needs a
paternalistic communication approach, as this offers him
reassurance (P17). Patients sometimes even make
demands of their physicians by telling them what to do
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(GP03). Family members also highlighted the import-
ance of their expectations of physicians’ alleviating their
worries (A08), which physicians also expressed; the latter
reported that family members tended to turn to physi-
cians more quickly and frequently, and channeled parts
of the responsibility toward their children (CP08). Physi-
cians also highlighted their own responsibility when
defining the diagnosis as a process of weighing the
correct balance between clinical necessity and the will-
ingness to be confronted with the disease, and especially
in the case of parents (CP08).
Patients also described patients’ suppression mecha-
nisms in coping with their disease, which suggest the
necessity of a watchful physician (P47). A paternalistic
attitude is also associated with protection, and offers
hope by guiding patients in steps through a previously
unknown health condition (P09). Patients also expressed
the need for a general physician to lead them through
the course of the disease (P11). Specifically, elderly pa-
tients tended to fully rely on the physician’s information,
and reconciled themselves to their status rather than
pushing for further health improvement (P48).
Informed (individual) decision-making
Informed decision-making is directly linked to the expert
knowledge of many patients and family members, draw-
ing many parallels. Patients reported that they feel as
though they have no right to participate in the deci-
sion-making process in that the physicians focus on
their diseases, but they would prefer to be holistically
perceived as a person. Individual ideas are unwelcome,
but perceived as questioning the physician’s expertise
or authority (A12, P16). Similarly, physicians noted that
individual information searches may lead to conflicts
within the decision-making process between patients’
expectations and economic and medical action strat-
egies (CP03, EP01).
However, patients reported that they solely discuss
acute symptoms with their physicians. One case also
noted that physicians were only consulted for general
medical advice, as knowledge on this incredibly rare
disease is so scarce that they preferred to consult other
affected families (A12). Moreover, patients and family
members also decide upon the point at which they con-
sult a doctor, or whether they preferred to consider a
second opinion (A12, GP04, GP05, GP06, EP07, GP09,
CP02). Patients often manage their own basic daily care
for these diseases, as well as preventive measures, such
as sports and healthy nutrition (P54). Specifically, the
patients themselves attend to their own daily chronic
disease symptoms or discuss them in self-help groups
(A03, P37).
However, some physicians also support patients’ in-
formed individual decision-making processes by welcom-
ing their self-reliance (P11, GP03), and encourage laying
out the patients’ treatment choices (P10).
Some physicians report worry as a result of patients’
individual decisions. For example, if the physician de-
cides upon a therapy, the patient may refuse to take the
prescribed medication. The patient may oppose it due a
lack of readiness for a radical procedure and its associ-
ated side effects (P28). A similar pattern occurs when
patients are not involved in the decision-making process,
and consequently, patients or family members often
switch to a physician who more highly appreciates their
opinions (A01).
Further, patients often report a struggle with the phys-
ician, and especially when they feel something is wrong
but the physician cannot determine a diagnosis (P17,
P28) or patients would prefer a specific therapeutic
service (P38). Conflict also occurs when the physician
Table 3 Anchor examples for the “information exchange”
Identified Items Anchor Examples
Professional health knowledge on rare diseases “[...] Yes, I think that if I had the right diagnosis—if I had MS, for example, which was never really
excluded—but if I had this as a diagnosis, then I could have told every physician, ‘Look, I’ve got
MS.’ Then, everybody would know what that is, everybody would know what kind of constraints I
have, and one would eventually show a little consideration for me.” (Patient, female, P16)
Health information scope: Between feeding fear and
effective health management
“First, to protect the patient from himself, as the induced therapy wave or perhaps also false/ or
diagnostic wave can also be harmful. But I also see it as a question of capacity of our health care
system. That we are not able to smooth every false alarm induced by “chatrooms” through
profound information coming from physicians.” (GP04)
The “expert patient” “Especially those exchange websites. [I1: Um]. That he comes to me, and then somehow has
enormous expectations and wants to tell me how it needs to be done [or not done], that’s difficult
for me; but he can be right. Thus, I mean, who is the specialist for these diseases? Actually it’s the
person afflicted. ‘Well, he’s got the symptoms, he knows how it was diagnosed, and he also knows
what works for him.’ The real specialist on the disease is in general the sick person. When it comes
to common diseases, we are also experts, because we experience them so often. When it comes to
rare diseases—well, I think if the physicians were honest, they are sometimes just helpless, because,
they just do not have it that often.” (Physician, female, 42 years, KA07)
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urges health services that the patient opposes (P38). In
contrast, physicians also struggle with patients who they
describe as “overly engaged,” in that some patients at-
tempt to pin down a diagnosis the physician does not
endorse (GP03, GP09). In this case, decision-making in
the rare disease field can play a specific role when there
is no initial decision to make due to missing therapy
options (P26). Another physician also described his
struggle with solely servicing patient wishes, although he
prefers to retain primary control of diagnoses (GP09).
Shared decision-making
The SDM concept was rarely described across all inter-
views, suggesting that it has not yet integrated into
common healthcare practice—or at least in the rare dis-
ease field.
One patient emphasized the trust-based relationship
with her physician achieved through the SDM process.
Although she initially denied therapy, the application of
SDM nurtured a trustful relationship, in that she finally
admitted that if the physician determines she needs ther-
apy, she will cooperate (P28).
Similarly, physicians can offer different therapeutic op-
tions but leave the final treatment choice to the patient
(P24).
On the one hand, another positive effect of shared
decision-making is that it can lead to the patient’s
self-responsible understanding of their own disease
and adherence to existing therapy options (P33). On
the other hand, interviews confirm that although
people affected with rare diseases depend on their
physician’s expert knowledge, ignoring patient prefer-
ences can still lead to a change in physician (A03).
For example, decisions can be made during a consult-
ation that the patient does not agree with (P38), the
patient and physician can disagree with diagnostic
procedures (P39), or a specific therapy may not be
prescribed (P30, P34).
Physicians admit that shared decision-making’s role
is increasing, as patients want their own perspectives
to be considered (EP04). Shared decisions’ importance
has also evolved, as diagnoses can be made after a
longer period of subtle symptoms. In this case, the
disease has already lead to irreversible, adverse effects
that patients must cope with as they struggle with
whether the physician should have intervened at an
earlier point in time (P49). The physician’s learning
of the patient’s perspective and their medical and
family history can lead to a better understanding of
the disease (P22, EP08).
The following Table 4 summarizes the findings for
Item 4 and provides corresponding anchor examples:
Discussion
Summary of findings
The underlying interview study revealed that medical de-
cision-making as a part of the patient-physician inter-
action is particularly relevant in the rare disease field
due to a many medical contacts and a high dependency
on the exchange and physicians’ engagement in general.
All parts of the SDM process, as systematically added to
existing literature using Charles et al.’s [6] framework,
were indicated as increasingly relevant within the rare
disease field in practice. However, the status quo
demonstrates that the SDM agreement itself was rarely
depicted or respectively perceived. In summary, the pa-
tient-physician encounter was characterized by a
balancing of trust and mistrust and high dependencies,
including an often-reported stigmatization of patients as
stimulants and many participants were involved. Com-
mitment was high due to a pronounced engagement of
those affected. Within the information communication
Table 4 Anchor examples for “decision-making and agreement”
Identified Items Anchor Examples
Paternalistic communication “He knew [the disease], but I think […] he wanted to protect me. I had this feeling. He said, ‘Okay, we will first look at this.’
So first of all, [he] very slowly introduced the disease, and I had that feeling. And there was no malevolence, rather the
contrary, he did know the disease very well, I have to admit. As I said, I cannot say ‘I think,’ but rather protection, so he
rather wanted to protect the parents. No pessimism with such a disease and no giving up of hope, but rather, he said,
‘Let’s first of all wait and to the contrary care for it. First of all, you move on with your life as it is, you keep working and
everything, not giving up anything.’” (Family member, female, A09)
Informed (individual)
decision-making
“Therefore, I actually see my task in keeping the strings together during a transfer on my own, and I’d like to be invited to
fill out one or another transfer form from somebody with a lot of knowledge. But to just nod something through in
retrospect, that I have some reluctance with.” (Physician, male, GP09)
Shared decision-making “[…] It really helped me, and if I listened to my physician, I would have taken Hydrea since 2009. These are chemo tablets,
which have a lot of side effects. Where one asks himself or herself, ‘What is really the benefit? And what’s actually the best
way to go?’ And that’s what Professor [NAME] does and that’s what he confirmed as unambiguous: that I can […] decide
as a patient on my own as well. That I feel it on my own, and that I rather know what’s good for me. But that does not
mean that he only speaks according to his audience, or that he tells me only what he thinks I want to hear. On the
contrary, […] I can say that after this conversation I have gotten so far to say, if Professor [NAME] says that it’s time for
therapy, […] it’s time for therapy.” (Patient, female, P28)
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process, the particular roles of “expert patients” or “lay
experts” in the rare disease field came forth; physicians’
and patients’ perspectives were triangulated to validate
these findings, and all items were verified in their
importance.
Findings in the context of literature
First, this study analyzed the “relationship between the
patient and physician” in Charles et al.’s [6] shared deci-
sion-making concept. The analysis revealed an imbal-
ance between trust and mistrust in the rare disease
field, whereby a trusting patient-physician relationship
is a prerequisite for effective communication. Georgo-
poulou, Prothero, and D’Cruz [35], Dowell et al. [13],
and the Royal Pharmaceutical Society of Great Britain,
Merck, Sharp, and Dohme [14] all link a trusting
relationship with a physician to many positive health-
care outcomes. Von der Lippe, Diesen, and Feragen
[36] further deepen this analysis by describing a
mistrust of doctors, and linking this to patients’ emo-
tional reactions. Further, Ernstmann et al. [37] found
a positive relationship between trust and patient
enablement, validating our overall finding that shared
decision-making is still infrequently used in practice
in the rare disease field.
The interviews revealed that a trusting relationship can
be nurtured by, on the one hand, medical experts’ trans-
parent communication of rare disease knowledge, and on
the other hand, their own engagement in the form of
transfers or time invested. Literature notes transparent
communication as one potential option among other
tools, such as technical and interpersonal competence,
physician agency, physician control, confidentiality, open
communication, and disclosure [38] by systemizing the
narrated items.
Aspects that undermine a trusting relationship and
should be avoided include misdiagnoses, a lack of em-
pathy, the lack of a constant contact person, the denying
of treatments, and the “guinea pig” role in patients’
disease treatment when therapy options are scarce.
These findings can shift the awareness to rare diseases
that lack approved medications [39].
Further many patients report being placed in the
“psychosomatic corner”, which hinders effective
disease management. The acknowledgement of symp-
toms feeds into the patient-physician relationship
Patients often report depending on a good physician,
which they are “lucky” to have found. In this context,
D’Elia [40] suggests a general listening concept for
physicians to appreciate the entire possible spectrum
of emotions that highlight doctors’ valuable roles as
social figures.
Finally, interactions are also characterized by the many
participants involved. Other physicians as well as family
members can be added to the standard patient-physician
interaction. They illustrate this linked network’s extent.
Blöß et al. [41] verify these findings along the “diagnostic
odyssey” of people suffering with rare diseases from the
health expert’s perspective, and conclude that diagnostic
procedures still need major improvements in the rare
disease field, especially in classifying incredibly rare
diseases. Alternatively, Dudding-Byth [42] describes the
transfers and diagnostics processes that general practi-
tioners face.
In a second step, we carved out the extent of “partici-
pation during the decision-making process.” Interviews
suggest that rare diseases necessitate a broader extent of
engagement, and consequently more time and effort.
This is especially the case in times of diagnosis, as
patients search for applicable therapy options and the
initiation of medical treatment. People affected—either
those who have lived with their diseases for a long time,
and/or those who have chosen to settle with their
diseases and take a more passive role—hand over their
responsibilities to the doctor in a preferable “supervisory
relationship.” Tofan et al. [43] describe this process in
the agency theory context; in his eyes this is rational
behavior, as one presumes physicians fully follow the
Hippocratic tradition.
In contrast, reports also describe an active, engaged
attitude within the healthcare system, in that patients
may travel several hundred kilometers to find the
right physician or specialized rare diseases center.
The subsequent efforts are extensive, especially when
young children are affected. Similarly, Dellve et al.
[44] describe the high pressure parents face in the
rare disease field.
Interviews confirm the particular relevance of “infor-
mation exchange” in the rare disease field. The identified
themes highlight the scarce professional healthcare
knowledge on rare diseases, the ideal scope of health
communications, as well as the people affected, who be-
come “patient experts” or “lay experts” on their diseases.
Literature often quotes this concept [26, 45], but this is
also confirmed during this study. These interviews
augment this concept and depict physicians’ difficult
role, which shifts from a health information monopoly
[46] to a new role as the sorter and structurer of avail-
able rare disease information.. Literature presents similar
concerns from critics of the SDM model, who argue that
most patients do not want to participate in such deci-
sions, and revealing the uncertainties in medicine should
be harmful. Further, while presenting all the potential
risks and benefits across all treatment options is not
feasible, the greatest concern is that increasing patient
involvement in decision-making can lead to a greater
demand for unnecessary, costly, or harmful medical
procedures [47]. Therefore, the ultimate goal should be
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to quantify costs and benefits in a controlled health-eco-
nomic setting.
Potentials exist for patients who enthusiastically
collect data, either from the Internet or from many
interactions with experts during their path through the
healthcare system. However, this potential is still hin-
dered at a communication level, as the people affected
may be concerned with negative reactions in their inter-
actions with professionals. Literature also often describes
Internet-based health information searches. For example,
McMullan [48] notes different access timeframes, and
highlights the threat resulting from information sources
of diverging quality [45, 49, 50].
Finally, the last item suggested by Charles et al. [6]
is the decision-making agreement itself. This study’s
interviews presented all forms of decision-making and
agreement, and predominately described informed
individual decision-making followed by paternalistic
approaches. Although literature [7] suggests its in-
creasing prominence, remarkably the SDM concept
was rarely described. Further, SDM is difficult to
identify, as the items overlap and are often difficult to
grasp, as mutual acceptance and agreement can be
stated at one point in time but may not hold [6].
Eliacin et al. [9] analyze patients’ definitions of SDM
to discover that the understanding of the concept in
practice is consistent with literature. However, study
participants indicated that SDM is not limited to the
models suggested in literature.
Paternalistic approaches were depicted as unavoidable—
such as for example in emergency situations—. These
findings have also been reported by Budych, Helms, and
Schulz [51], although these authors do not provide a
context in which these approaches were welcome. Baron,
Reyher, and Stack [52] report positive outcomes from
paternalistic approaches in a crisis situation. The patients
in their study were treated paternalistically, and exhibited
a higher responsiveness to suggestibility (p > .001), felt
they could depend more on the physician, perceived him
as warmer and more supportive (p > .01), and expressed
fewer incidences of physiological distress compared with
patients treated in an egalitarian manner.
Informed decision-making was also often described
to highlight patients’ independence, and especially as
they decide when to consult a healthcare professional
and the extent to which patients consult their phys-
ician. Patients then decide whether to follow physi-
cians’ decisions or change medical consultants. Thus,
it is often assumed that patients prefer Internet-based
health information, while concerns simultaneously
exist that this would lead to extensive, costly health-
care [47].
In this context, the potential of the shared decision-
making process shows that integrating both “lay expert”
knowledge and efforts as well as professional knowledge
can soften conflicts and strengthen the rare diseases
network approach at its core. Well-conducted SDM
enhanced reported satisfaction, understanding, and con-
fidence in the decisions [53]. In this regard, strengthen-
ing the patient-physician relationship through SDM can
potentially diminish within the field of rare diseases the
highly relevant issue of doctor shopping. Others regard
the process of decision-making in its entirety, and
insinuate the importance of increased involvement of
participants and the approachability of providers [560].
Finally, observational studies with patients suffering
from hip and knee osteoarthritis showed they choose
less expensive medical procedures when SDM was
chosen as a decision-making tool resulting in a cost
reduction of approximately 12 to 21% [54]. This leads
to the assumption that cost-effectiveness can be fur-
ther improved through the implementation of such
concepts. Considering the potential, we suggest fur-
ther health economic evaluations in the field of rare
diseases to generate knowledge on the benefits of
such approaches.
The study’s significance
To our knowledge, the current study is unique in its ap-
proach: it complements Charles et al.’s [6] SDM model,
and integrates perspectives from physicians and patients’
family members concerning this matter across a range of
rare diseases. It also verifies findings from Budych,
Helms, and Schultz [51], who also advocated for a
conscious exchange of information in the rare disease
field, although not within the context of a set frame-
work. Moreover, they only focused on some rare
diseases and the patient’s perspective. The underlying
study covers all disease areas and integrates different
perspectives to illustrate a broader picture and contrib-
ute to an advocated network approach at a micro-level
in the healthcare system.
Patients’ perspectives at the macro-level are often
systematically included by involving patient represen-
tatives. At the meso-level, it has been demonstrated
that group decision-making tools can systematically
integrate patient perspectives [21]. Thus, the question
arises regarding which tool should be chosen to fur-
ther implement SDM in practice. Literature suggests
coaching programs or workshops [55], as well as deci-
sion boxes or tools led by nurses [11]. Scholl et al.
[56] report the limited validity of SDM tools, and
indicate why such concepts may not have been estab-
lished in practice. Further, Elwyn et al. [5] describe
criteria for a practical implementation to overcome
these hurdles.
The patient participation concept has been inte-
grated within Germany’s national plan for cancer care
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thus far, but has not yet become an integral part of
the German rare disease national plan [20]. Following
the model established by the national plan for cancer-
ous diseases, patient perspectives can also become
systematically integrated at the micro-health and eco-
nomic levels. This can be accomplished by integrating
SDM within various concepts for further development
in the field, therefore ensuring and controlling its
long-term application.
Assumptions and limitations
This study was conducted using qualitative interviews,
and participants were encouraged to report their experi-
ences with the healthcare system during their disease
diagnosis and management, assuming that this reflects
the actual subjective relevance in the decision-making
process. The statements’ validity have been verified by
triangulation. Therefore, only a limited number of
patients, family members, and physicians could be inter-
viewed, but the number of participants was sufficient as
a base knowledge generation was achieved. The qualita-
tive design contributes to theory generation by gathering
relevant items and avoiding absolute numerical state-
ments; results must be verified through a quantitative
study to make further projections and/or obtain
evidence.
Shared-decision making was not addressed as such
within the interview guide. Participants were not
directly asked about SDM, but rather indirectly about
their experiences within healthcare systems and
health management during the information-gathering
process. This approach bears some risk, in that some
interviews may involve situations in which SDM did
not occur. One advantage of this approach is its iden-
tification of the actual perceptions of SDM, decreas-
ing potential biases. By avoiding the SDM concept
but focusing on informed health behavior, participants
cannot be cued regarding how to answer the question
to appease the researchers [57]. However, this also
bears the risk that the concept may not impose itself
in its full extensity, as it was avoided to pinpoint
participants towards the concept, by directly asking
for it.
The interview study was conducted in 2014, but sev-
eral new rare disease centers have been subsequently
established, and a national rare disease plan has been
pushed toward implementation. However, the general
structure of this matter has not changed to impact the
German healthcare system.
Besides, we did not interview the treating physicians
of the included patients and or their family members
due to organizational restraints. The patients inter-
viewed in the current study were predominantly
female; in this context, Wyatt et al. [58] reveal that
no gender specifications exist in decisional conflicts,
patients’ satisfaction with the clinical encounter, or
patients’ engagement at the point of encounter. Only
an increased concordance between decisions and
actions were described in encounters with female
clinicians, while male patients demonstrated an in-
creased concordance in the decision aid arm com-
pared to the control arm (p = 0.05). Further, women
more actively manage their healthcare status; for
example, woman search more often for Internet-based
health information [59].
Conclusions
To the best of our knowledge, this study is the first to
provide unique insights on the decision-making practice
and SDM’s current relevance within the rare disease
field. While SDM is increasingly present, the reported
processes still lack many aspects of the decision-making
process in this area. Further, a shared decision-making
agreement was more rarely reported; the patient-phys-
ician relationship was characterized by a distorted trust--
building process; and such characteristics of rare
diseases as genetic origins, severity, and chronic course
may lead to patients’ high dependencies on their physi-
cians. Patients may also often suffer from stigmatization
as stimulants. Although the physicians in our study
noted that they would need further time to analyze rare
disease cases, participation was comparably pronounced
regarding their patient-side engagement. Political health
efforts should strive toward these efforts and promote
diminishment as strengths vanish during the odyssey
through healthcare systems. The particular role of “ex-
pert patients” or “lay experts” in the rare disease field
has again unfolded, and potential especially surfaces
regarding the integration of the information gathered
during the decision-making process.
The aforementioned efficiency potentials can be trig-
gered through a further integration of shared decision-
making, facilitating diagnostics and disease management.
It is also noteworthy that the integration of shared deci-
sion-making in the rare disease field not only requires
strengthening patients’ positioning, but also the position-
ing of physicians. These potentials can be triggered by
implementing further SDM processes within the rare
disease field, for example, through integrating participat-
ing decision-making concepts within rare disease na-
tional plans, as has already been accomplished in the
cancerous disease field. This can provide an opportunity
to reinforce a crucially relevant networking approach,
strengthened by rare disease centers and guides at its
core, on a micro-level, and within patient-physician in-
teractions. Further research can quantify this potential
and examine the health-economic impacts of shared de-
cision-making on overall healthcare spending.




This is for patients and their relatives when a diagnosis
can be consciously discerned.
Question 1:
- I would like you to remember the onset of your /
your relative’s disease. What kind of changes did you
perceive?
- Optional subquestion(s):
o Can you remember specific events?
o What kind of changes became noticeable within
your body?
o To what extent did you perceive changes within your
social environment?
o If the disease was diagnosed at birth, continue with
Section II.
Question 2:
- How did the diagnosis occur?
Question 3:
- What happened after the diagnosis?
- Optional subquestion:
o How did the illness progress from there?
Question 4:
When you place yourself back in the situation, what
did you feel?
Section II: Disease.
This is for patients only, when a diagnosis was not
consciously discerned.
Question 1:
- I would like you to tell me about your disease and
how your life changed. You may take all the time neces-
sary for your answer.
Appendix 1
Table 5 Characteristics of patients, family members, and









Male 18 5 23
Female 37 8 10
Age
Average 52 44 48
Maximum 85 60 68
Minimum 18 28 31
Civil status
No specification – 1 –
Married/cohabiting 34 9 –
Single 11 1 –
Divorced/Separated 7 1 –





Abitur 8 5 –
Advanced technical college degree 5 0 –




Members of the household –
Average 2,09 3,58 –
Maximum 5 5 –
Minimum 1 1 –
Age at diagnosis
Average 37 8 –
Maximum 74 39 –
Minimum 0 0 –
Disease severity
No specification – 0 –
Low 5 3 –
Medium 26 2 –
Severe 21 7 –
Profession
Employed 22 9 –
Unemployable 12 1 –
Pensioner 18 – –
Student/Scholar 2 – –
Homemaker – 2 –
Special circumstances 1 – –
Medical rare disease experience / – – 6
Table 5 Characteristics of patients, family members, and










Rural – – 3
Urban – – 7
Metropolitan – – 8
Practice form
Single practice – – 7
Group practice – – 11
Clinic level
Basic – – 4
Regular – – 0
Specialist – – 1
Maximum medical care – – 4
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- Optional subquestion:
o Describe the course of the disease. (For example:
Were there any acute phases?)
Question 2:
- How did the illness manifest in your everyday life?
- Optional subquestion:
o Have you experienced any limitations, and if so,
what kind?
Question 3:
- Some people have the desire to become informed
themselves about disease. How is it with you?
- Optional subquestion:
o Can you describe a situation in which you desired to
acquire more information about your disease and its
management?
Section III: The search and need for information.
Question 1:
- Describe searching for information about the hand-
ling of your disease.
- Optional subquestion(s):
o Please try to remember what kind of information
you searched for.
o Where did you find the information?
o How satisfied were you with your search results?
Question 2:
- Were there any events before or after which you
more intensely searched for information?
- Optional subquestion(s):
o How did you proceed with your search?
Question 3:
- To what extent were there situations in which you
could easily access information?
- Optional subquestion(s):
o What types of information were these?
Question 4:
- To what extent were there situations in which you
strove to find information, but could not find it?
- Optional subquestion(s):
o What types of information were these?
o What kind of information would you wish for?
o What kind of information do you think you will
need in the future?
Question 5:
- What moments were significant during your search?
- Optional subquestion(s):
o Was there a point in time at which you felt you had
achieved a breakthrough?
Section IV: Media or respective information access
points.
Question 1:
- Please consider the many possibilities through which
one can presently communicate with the help of modern
or classic media. When you consider your own situation,
what possibilities did you use during your own search?
- Optional subquestion(s):
- What do you comprehend as the communication
possibilities for modern and classic media, respectively?
Question 2:
- In what ways would you like to access information?
- Optional subquestion(s):
o Would you also like to access information using
your mobile device or smartphone?
o What is your opinion of accessing information
through social media, such as Twitter or Facebook?
o For example, we have considered integrating a help-
line as part of a national information website. What is
your opinion regarding the possibility of a helpline?
How do you envision such a helpline?
Section V: Windup.
Question:
- Are there any other topics that you would like to
address?
- Optional subquestion(s):
o Are there any other important aspects that we have
not yet addressed?
Abbreviations
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